Apply for Cancer Control Grants

The Division of Cancer Control and Population Sciences funds a large portfolio of grants and contracts. The portfolio currently includes over 700 grants, valued at nearly $440 million. Here we provide a listing of funding opportunities that are currently accepting applications. Please visit this page regularly as new funding opportunities are added upon approval by NCI.

For information on the portfolio of over 700 grants, please go to Research Portfolios section of this website.


Title Announcement # / Mechanism(s) Activity Code Clinical Research Expiration Date Program Contact Funding Type Research Category
Stephen I. Katz Early Stage Investigator Research Project Grant PAR-21-039 R01 Basic Experimental Studies with Humans Required December 29, 2023

Scott Rogers
240-276-6932
rogerssc@mail.nih.gov

PAR Parent and Omnibus Funding Announcements
Stephen I. Katz Early Stage Investigator Research Project Grant PAR-21-038 R01 Clinical Trial Not Allowed December 29, 2023

Scott Rogers
240-276-6932
rogerssc@mail.nih.gov

PAR Parent and Omnibus Funding Announcements
New Cohorts for Environmental Exposures and Cancer Risk (CEECR) Coordinating Center RFA-CA-20-050 U24 Clinical Trial Not Allowed January 30, 2021

Somdat Mahabir
240-276-6914
mahabir@mail.nih.gov

RFA Epidemiology and Genomics Research
New Cohorts for Environmental Exposures and Cancer Risk (CEECR) RFA-CA-20-049 UG3, UH3 Clinical Trial Not Allowed January 30, 2021

Somdat Mahabir
240-276-6914
mahabir@mail.nih.gov

RFA Epidemiology and Genomics Research
Utilizing In Vitro Functional Genomics Advances for Gene-Environment (G x E) Discovery and Validation RFA-ES-20-018 R01 Clinical Trial Not Allowed February 02, 2021

Stefanie Nelson
240-276-6944
nelsons@mail.nih.gov

RFA Epidemiology and Genomics Research
Notice of Special Interest (NOSI): Health Services Research on Minority Health and Health Disparities NOT-MD-20-011 R01 Clinical Trial Optional September 08, 2022

Brenda Adjei
240-276-6185
adjeiba@mail.nih.gov

Notices - including Notices of Special Interest (NOSIs) Healthcare Delivery Research, Health Disparities
Notice of Special Interest (NOSI): Obesity Policy Evaluation Research NOT-DK-20-035 Clinical Trial Not Allowed September 08, 2023

David Berrigan
240-276-6752
berrigad@mail.nih.gov

Jill Reedy
240-276-6812
reedyj@mail.nih.gov

Notices - including Notices of Special Interest (NOSIs) Epidemiology and Genomics Research, Health Behaviors Research
Fertility Status as a Marker for Overall Health PAR-20-282 R21 Clinical Trial Not Allowed June 20, 2023

Lisa Gallicchio
240-276-5741
Lisa.gallicchio@nih.gov

PAR Epidemiology and Genomics Research
Fertility Status as a Marker for Overall Health PAR-20-281 R01 Clinical Trial Optional June 20, 2023

Lisa Gallicchio
240-276-5741
Lisa.gallicchio@nih.gov

PAR Epidemiology and Genomics Research
Investigator-Initiated Research on Genetic Counseling Processes and Practices RFA-HG-20-048 R01 Clinical Trial Optional July 09, 2021

Leah Mechanic
240-276-6847
mechanil@mail.nih.gov

RFA Epidemiology and Genomics Research, Healthcare Delivery Research
Notice of Special Interest (NOSI): Research in the Emergency Setting NOT-NS-20-005 September 08, 2022

Nonniekaye Shelburne
240-276-6897
nshelburne@mail.nih.gov

Notices - including Notices of Special Interest (NOSIs) Epidemiology and Genomics Research, Healthcare Delivery Research
Social and Behavioral Intervention Research to Address Modifiable Risk Factors for Cancer in Rural Populations RFA-CA-20-051 R01 Clinical Trial Required January 19, 2022

Kelly Blake
240-281-5934
kelly.blake@nih.gov

RFA Health Behaviors Research, Health Communication and Informatics Research, Health Disparities, Implementation Science, Tobacco Control Research
Tobacco Control Policies to Promote Health Equity PAR-20-302 R01 Clinical Trial Optional September 08, 2023

Bob Vollinger
240-276-6919
bob.vollinger@nih.gov

PAR Tobacco Control Research
Tobacco Control Policies to Promote Health Equity PAR-20-303 R21 Clinical Trial Optional September 08, 2023

Bob Vollinger
240-276-6919
bob.vollinger@nih.gov

PAR Tobacco Control Research
NIH Research Project Grant PA-18-484 R01 Clinical Trial Not Allowed May 08, 2023

Research Program Contacts

PA Parent and Omnibus Funding Announcements
Mechanisms and Consequences of Sleep Disparities in the U.S. PAR-20-164 R01 Clinical Trial Not Allowed July 15, 2022 PAR Health Behaviors Research
Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements PA-18-935 Clinical Trial Optional January 25, 2022

Research Program Contacts

PA, Parent Announcements
Administrative Supplements to Existing NIH Grants and Cooperative Agreements PA-18-591 Clinical Trial Optional January 26, 2021

Research Program Contacts

PA, Parent Announcements
Notice of Amendment of NCI Participation in PAR-20-164, Mechanisms and Consequences of Sleep Disparities in the U.S. NOT-CA-20-075

Kara Hall
240-276-6831
hallka@mail.nih.gov

Todd Horowitz
240-276-6963
horowitzts@mail.nih.gov

Notices - including Notices of Special Interest (NOSIs) Health Behaviors Research
Identifying Innovative Mechanisms or Interventions that Target Multimorbidity and Its Consequences PAR-20-180 R01 Clinical Trial Optional September 08, 2023

Bryan Kim
240-276-6669
bryan.kim@nih.gov

Helpful Resources

PAR Basic Biobehavioral and Psychological Sciences, Healthcare Delivery Research
Advancing Research to Develop Improved Measures and Methods for Understanding Multimorbidity PAR-20-179 R01 Clinical Trial Optional September 08, 2023

Bryan Kim
240-276-6669
bryan.kim@nih.gov

Helpful Resources

PAR Basic Biobehavioral and Psychological Sciences, Healthcare Delivery Research
Multilevel Interventions in Cancer Care Delivery: Follow-up to Abnormal Screening Tests PA-17-495 R01 Clinical Trial Optional January 08, 2021 Erica Breslau
240-276-6773
breslaue@mail.nih.gov
PA Healthcare Delivery Research
Mid-Career Enhancement Awards to Integrate Basic Behavioral, Biomedical, and/or Social Scientific Processes PAR-20-211 K18 Independent Clinical Trial Not Allowed March 18, 2023

Gina Tesauro
240-276-6786
gina.tesauro@nih.gov

PAR Basic Biobehavioral and Psychological Sciences
Notice of Special Interest (NOSI): Development of Statistical, Population Genetics and Computational Methods Related to Polygenic Prediction of Health and Disease in Diverse Populations NOT-HG-20-010 October 05, 2023 Leah Mechanic
240-276-6847
mechanil@mail.nih.gov
Notices - including Notices of Special Interest (NOSIs) Epidemiology and Genomics Research
NCI Small Grants Program for Cancer Research PAR-20-052 R03 Clinical Trial Optional January 08, 2023

Research Program Contacts

PAR, Parent Announcements Parent and Omnibus Funding Announcements
Co-infection and Cancer PAR-20-061 R21 Clinical Trial Not Allowed January 08, 2023 Tram Kim Lam
240-276-6967
lamt@mail.nih.gov
PAR Epidemiology and Genomics Research
Co-infection and Cancer PAR-20-062 R01 Clinical Trial Not Allowed January 08, 2023 Tram Kim Lam
240-276-6967
lamt@mail.nih.gov
PAR Epidemiology and Genomics Research
Fundamental Mechanisms of Affective and Decisional Processes in Cancer Control PAR-20-034 R01 Clinical Trial Optional January 08, 2023 Rebecca Ferrer
301-852-1167
rebecca.ferrer@nih.gov
PAR Basic Biobehavioral and Psychological Sciences
Perception and Cognition Research to Inform Cancer Image Interpretation PAR-19-387 R01 Clinical Trial Optional January 08, 2023 Todd Horowitz
240-276-6963
horowitzts@mail.nih.gov
PAR Basic Biobehavioral and Psychological Sciences
Perception and Cognition Research to Inform Cancer Image Interpretation PAR-19-389 R21 Clinical Trial Optional January 08, 2023 Todd Horowitz
240-276-6963
horowitzts@mail.nih.gov
PAR Basic Biobehavioral and Psychological Sciences
Mid-Career Enhancement Awards to Integrate Basic Behavioral, Biomedical, and/or Social Scientific Processes PAR-20-226 K18 Basic Experimental Studies with Humans Required March 18, 2023 Gina Tesauro
240-276-6786
gina.tesauro@nih.gov
PAR Basic Biobehavioral and Psychological Sciences
Notice of Special Interest (NOSI): Research on Oral Anticancer Agents in the Contexts of Utilization, Adherence, and Health Care Delivery NOT-CA-20-026 May 08, 2023

Wendy Nelson
240-276-6971
nelsonw@mail.nih.gov

Helpful Resources

Notices - including Notices of Special Interest (NOSIs) Basic Biobehavioral and Psychological Sciences, Epidemiology and Genomics Research, Healthcare Delivery Research
Advancing Research to Develop Improved Measures and Methods for Understanding Multimorbidity PAR-20-179 R01 Clinical Trial Optional September 08, 2023

Bryan Kim
240-276-6669
bryan.kim@nih.gov

Helpful Resources

PAR Basic Biobehavioral and Psychological Sciences, Healthcare Delivery Research
Identifying Innovative Mechanisms or Interventions that Target Multimorbidity and Its Consequences PAR-20-180 R01 Clinical Trial Optional September 08, 2023

Bryan Kim
240-276-6669
bryan.kim@nih.gov

Helpful Resources

PAR Basic Biobehavioral and Psychological Sciences, Healthcare Delivery Research
Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional) PA-20-172 R01 Clinical Trial Optional September 08, 2023 Sallie J. Weaver
(240) 276-6254
sallie.weaver@nih.gov
PA Health Disparities, Healthcare Delivery Research
Notice of Special Interest (NOSI): Alcohol and Cancer Control NOT-CA-20-034 September 09, 2023

Tanya Agurs-Collins
240-276-6956
collinsta@nih.gov

David Berrigan
240-276-6752
berrigad@nih.gov

Helpful Resources

Notices - including Notices of Special Interest (NOSIs) Health Behaviors Research
Notice of Special Interest (NOSI): Development and Preliminary Testing of Health-related Behavioral Interventions NOT-OD-20-106 September 26, 2022 Susan Czajkowski
240-276-5871
Susan.Czajkowski@nih.gov
Notices - including Notices of Special Interest (NOSIs) Health Behaviors Research
Integrative Research on Polysubstance Abuse and Disorder PAR-20-035 R61, R33 Clinical Trial Optional November 08, 2022 Annette Kaufman
240-276-6706
kaufmana@mail.nih.gov

David Berrigan
240-276-6752
berrigad@nih.gov
PAR Tobacco Control Research, Health Behaviors Research
Core Infrastructure Support for Cancer Epidemiology Cohorts PAR-20-294 U01 Clinical Trial Not Allowed November 10, 2022

Joanne Elena
240-276-6818
joanne.elena@nih.gov

PAR Cancer Survivorship, Epidemiology and Genomics Research
Notice of Special Interest (NOSI): Use of Biological "High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers NOT-CA-20-022 January 08, 2023

Vaurice Starks
301-624-1299
starksv@mail.nih.gov

Mukesh Verma
240-276-6889
vermam@mail.nih.gov

Notices - including Notices of Special Interest (NOSIs) Epidemiology and Genomics Research
Mentored Research Scientist Career Development Award in Tobacco Regulatory Research RFA-OD-20-011 K01 Independent Clinical Trial Required July 11, 2022 Rachel Grana Mayne
240-276-5899
rachel.mayne@nih.gov
RFA Tobacco Control Research
Mentored Research Scientist Career Development Award in Tobacco Regulatory Research RFA-OD-20-008 K01 Independent Clinical Trial Not Allowed July 11, 2022 Rachel Grana Mayne
240-276-5899
rachel.mayne@nih.gov
RFA Tobacco Control Research
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake PAR-19-359 R03 Clinical Trial Optional July 17, 2022 Sarah Kobrin
240-276-6931
kobrins@mail.nih.gov
PAR Healthcare Delivery Research, Implementation Science
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization PAR-19-352 R01 Clinical Trial Optional September 08, 2022 Michelle Mollica
240-276-7621
mollicama@mail.nih.gov
PAR Cancer Survivorship
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization PAR-19-355 R21 Clinical Trial Optional September 08, 2022 Michelle Mollica
240-276-7621
mollicama@mail.nih.gov
PAR Cancer Survivorship
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake PAR-19-360 R01 Clinical Trial Optional September 08, 2022 Sarah Kobrin
240-276-6931
kobrins@mail.nih.gov
PAR Healthcare Delivery Research, Implementation Science
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake PAR-19-358 R21 Clinical Trial Optional September 08, 2022 Sarah Kobrin
240-276-6931
kobrins@mail.nih.gov
PAR Healthcare Delivery Research, Implementation Science
Stimulating Innovations in Behavioral Intervention Research for Cancer Prevention and Control PAR-19-309 R21 Clinical Trial Optional September 08, 2022 Tanya Agurs-Collins
240-276-6956
collinsta@mail.nih.gov
PAR Health Behaviors Research, Implementation Science
Neural Regulation of Cancer PAR-19-353 R01 Clinical Trial Not Allowed May 28, 2022 Chamelli Jhappan
jhappanc@mail.nih.gov

Paige Green
240-276-6899
paige.green@nih.gov
PAR Basic Biobehavioral and Psychological Sciences
Neural Regulation of Cancer PAR-19-354 R21 Clinical Trial Not Allowed May 28, 2022 Chamelli Jhappan
jhappanc@mail.nih.gov

Paige Green
240-276-6899
paige.green@nih.gov
PAR Basic Biobehavioral and Psychological Sciences
Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment PAR-19-340 R01 Clinical Trial Optional June 09, 2022 Todd Horowitz
240-276-6963
horowitzts@mail.nih.gov
PAR Basic Biobehavioral and Psychological Sciences, Cancer Survivorship
Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment PAR-19-339 R21 Clinical Trial Optional June 09, 2022 Todd Horowitz
240-276-6963
horowitzts@mail.nih.gov
PAR Basic Biobehavioral and Psychological Sciences, Cancer Survivorship
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem PAR-19-348 R01 Clinical Trial Optional June 09, 2022 Kelly Blake
240-281-5934
kelly.blake@nih.gov
PAR Health Communication and Informatics Research
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem PAR-19-350 R21 Clinical Trial Optional June 09, 2022 Kelly Blake
240-281-5934
kelly.blake@nih.gov
PAR Health Communication and Informatics Research
Pathway to Independence Award in Tobacco Regulatory Research RFA-OD-20-010 K99, R00 Independent Clinical Trial Required July 11, 2022 Rachel Grana Mayne
240-276-5899
rachel.mayne@nih.gov
RFA Tobacco Control Research
Pathway to Independence Award in Tobacco Regulatory Research RFA-OD-20-009 K99, R00 Independent Clinical Trial Not Allowed July 11, 2022 Rachel Grana Mayne
240-276-5899
rachel.mayne@nih.gov
RFA Tobacco Control Research
Dissemination and Implementation Research in Health (Domestic and International Funding Opportunity) PAR-19-276 R03 May 08, 2022 Gila Neta
240-276-6785
netagil@mail.nih.gov

Cynthia A. Vinson
240-276-6745
cvinson@mail.nih.gov
PAR Implementation Science
Notice of Special Interest (NOSI): Dissemination and Implementation Science for Cancer Prevention and Control in Low Resource Environments NOT-CA-20-025 May 08, 2022 Mark Parascandola
240-276-6871
paramark@mail.nih.gov
Notices - including Notices of Special Interest (NOSIs) Tobacco Control Research, Health Behaviors Research, Health Disparities, Implementation Science
Notice of Special Interest (NOSI): De-implementation of Ineffective or Low-value Clinical Practices along the Cancer Care Continuum NOT-CA-20-021 May 10, 2022

Erica Breslau
240-276-6773
breslaue@mail.nih.gov

Wynne E. Norton
240-276-6875
wynne.norton@nih.gov

Notices - including Notices of Special Interest (NOSIs) Implementation Science
Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations PA-18-932 R01 Clinical Trial Optional January 08, 2022 Erica Breslau
240-276-6773
breslaue@mail.nih.gov
PA Healthcare Delivery Research, Implementation Science
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies PAR-19-325 R01 Clinical Trial Optional February 12, 2022 Kelly Filipski
240-276-6841
Filipskikk@mail.nih.gov
PAR Epidemiology and Genomics Research, Cancer Survivorship
Mechanisms of Disparities in Chronic Liver Diseases and Cancer PAR-20-088 R01 Clinical Trial Not Allowed April 02, 2022 Tram Kim Lam
240-276-6967
lamt@mail.nih.gov
PAR Health Disparities, Epidemiology and Genomics Research
Mechanisms of Disparities in Chronic Liver Diseases and Cancer PAR-20-081 R21 Clinical Trial Not Allowed April 02, 2022 Tram Kim Lam
240-276-6967
lamt@mail.nih.gov
PAR Health Disparities, Epidemiology and Genomics Research
Biology of Bladder Cancer PAR-19-184 R21 Clinical Trial Optional May 08, 2022 Tram Kim Lam
240-276-6967
lamt@mail.nih.gov
PAR Epidemiology and Genomics Research
Biology of Bladder Cancer PAR-19-183 R01 Clinical Trial Optional May 08, 2022 Tram Kim Lam
240-276-6967
lamt@mail.nih.gov
PAR Epidemiology and Genomics Research
Dissemination and Implementation Research in Health (Domestic and International Funding Opportunity) PAR-19-274 R01 Clinical Trial Optional May 08, 2022 Gila Neta
240-276-6785
netagil@mail.nih.gov

Cynthia A. Vinson
240-276-6745
cvinson@mail.nih.gov
PAR Implementation Science
Dissemination and Implementation Research in Health (Domestic and International Funding Opportunity) PAR-19-275 R21 Clinical Trial Optional May 08, 2022 Gila Neta
240-276-6785
netagil@mail.nih.gov

Cynthia A. Vinson
240-276-6745
cvinson@mail.nih.gov
PAR Implementation Science
Notice of Special Interest (NOSI): Geospatial Approaches in Cancer Control and Population Sciences NOT-CA-20-004 January 08, 2022

Armen Ghazarian
240-276-7305
ghazarianaa@mail.nih.gov

April Oh
240-276-6709
ohay@mail.nih.gov

Zaria Tatalovich
240-276-6976
tatalovichzp@mail.nih.gov

Notices - including Notices of Special Interest (NOSIs) Epidemiology and Genomics Research, Health Communication and Informatics Research
Notice of Special Interest (NOSI): Use of Biological Information to Understand How the Interplay of Environmental Exposures and Genes Influences Cancer Risk NOT-CA-20-002 January 08, 2022

Stefanie Nelson
240-276-6944
nelsons@mail.nih.gov

Armen Ghazarian
240-276-7305
ghazarianaa@mail.nih.gov

Notices - including Notices of Special Interest (NOSIs) Epidemiology and Genomics Research
Notice of Special Interest (NOSI): NCI's Research Interests to Improve Interprofessional Teamwork and Coordination During Cancer Diagnosis and Treatment NOT-CA-19-059 January 08, 2022 Sallie J. Weaver
240-276-6254
sallie.weaver@nih.gov

Veronica Chollette
240-276-6969
cholletv@mail.nih.gov
Notices - including Notices of Special Interest (NOSIs) Healthcare Delivery Research, Cancer Survivorship
End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses PAR-19-136 R01 Clinical Trial Optional January 08, 2022 Ashley Wilder Smith
240-276-6714
smithas@mail.nih.gov
PAR Healthcare Delivery Research, Cancer Survivorship
End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses PAR-19-153 R21 Clinical Trial Optional January 08, 2022 Ashley Wilder Smith
240-276-6714
smithas@mail.nih.gov
PAR Healthcare Delivery Research, Cancer Survivorship
Time-Sensitive Obesity Policy and Program Evaluation PAR-18-854 R01 September 11, 2021 David Berrigan
240-276-6752
David.Berrigan@nih.gov

Jill Reedy
240-276-6812
reedyj@mail.nih.gov
PAR Health Behaviors Research, Epidemiology and Genomics Research
Exploratory Grants in Cancer Epidemiology and Genomics Research PAR-19-277 R21 Clinical Trial Optional October 09, 2021 Mukesh Verma
240-276-6889
vermam@mail.nih.gov
PAR Epidemiology and Genomics Research
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity PA-19-112 R01 Clinical Trial Optional January 08, 2022 Nonniekaye Shelburne
240-276-6897
nshelburne@mail.nih.gov
PA Epidemiology and Genomics Research, Cancer Survivorship
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity PA-19-111 R21 Clinical Trial Optional January 08, 2022 Nonniekaye Shelburne
240-276-6897
nshelburne@mail.nih.gov
PA Epidemiology and Genomics Research, Cancer Survivorship
End-of-Life and Palliative Care Health Literacy: Improving Outcomes in Serious, Advanced Illness PA-18-499 R21 Clinical Trial Optional May 08, 2021 Sylvia Chou
240-276-6954
chouws@mail.nih.gov
PA Health Communication and Informatics Research, Cancer Survivorship
Native American Research Centers for Health (NARCH) PAR-20-125 S06 Clinical Trial Optional July 24, 2021 Shobha Srinivasan
240-276-6938
sriniva2@mail.nih.gov
PAR Health Disparities
Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors RFA-CA-20-027 R01 Clinical Trial Optional July 31, 2021

Michelle Mollica
240-276-7621
michelle.mollica@nih.gov

Danielle Daee
240-276-5744
danielle.daee@nih.gov

RFA Cancer Survivorship, Epidemiology and Genomics Research, Healthcare Delivery Research
Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors RFA-CA-20-028 R21 Clinical Trial Optional July 31, 2021

Michelle Mollica
240-276-7621
michelle.mollica@nih.gov

Danielle Daee
240-276-5744
danielle.daee@nih.gov

RFA Cancer Survivorship, Epidemiology and Genomics Research, Healthcare Delivery Research
Notice of NCI's Participation on PAR-19-368, Accelerating the Pace of Drug Abuse Research Using Existing Data NOT-CA-20-061 R01 Clinical Trial Optional September 08, 2021 Carolyn Reyes-Guzman
240-276-7244
carolyn.reyes-guzman@nih.gov
Notices - including Notices of Special Interest (NOSIs) Tobacco Control Research, Basic Biobehavioral and Psychological Sciences, Health Behaviors Research
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival PAR-18-893 R01 Clinical Trial Optional September 08, 2021 Frank Perna
240-276-6782
pernafm@mail.nih.gov
PAR Cancer Survivorship, Health Behaviors Research
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival PAR-18-892 R21 Clinical Trial Optional September 08, 2021 Frank Perna
240-276-6782
pernafm@mail.nih.gov
PAR Cancer Survivorship, Health Behaviors Research
Diet and Physical Activity Assessment Methodology PAR-18-857 R21 Clinical Trial Not Allowed September 08, 2021 Richard Troiano
240-276-6916
troianor@mail.nih.gov

Kirsten Herrick
240-276-5734
herrickka@mail.nih.gov
PAR Epidemiology and Genomics Research
Diet and Physical Activity Assessment Methodology PA-18-856 R01 Clinical Trial Not Allowed September 08, 2021 Richard Troiano
240-276-6916
troianor@mail.nih.gov

Kirsten Herrick
240-276-5734
herrickka@mail.nih.gov
PA Epidemiology and Genomics Research
Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study PAR-19-162 R01 Clinical Trial Not Allowed September 08, 2021 Annette Kaufman
240-276-6706
kaufmana@mail.nih.gov
PAR Tobacco Control Research
Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study PAR-19-163 R21 Clinical Trial Not Allowed September 08, 2021 Annette Kaufman
240-276-6706
kaufmana@mail.nih.gov
PAR Tobacco Control Research
End-of-Life and Palliative Care Health Literacy: Improving Outcomes in Serious, Advanced Illness PA-18-498 R01 Clinical Trial Optional May 08, 2021 Sylvia Chou
240-276-6954
chouws@mail.nih.gov
PA Health Communication and Informatics Research, Cancer Survivorship
Secondary Analyses of Existing Datasets of Tobacco Use and Health RFA-OD-19-022 R21 Clinical Trial Not Allowed March 09, 2021 Rachel Grana Mayne
240-276-5899
rachel.mayne@nih.gov
RFA Tobacco Control Research
Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery PAR-19-373 R01 Clinical Trial Not Allowed March 18, 2021 Rebecca Ferrer
301-852-1167
rebecca.ferrer@nih.gov
PAR Basic Biobehavioral and Psychological Sciences
Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery PAR-19-384 R01 Basic Experimental Studies with Humans Required March 18, 2021 Rebecca Ferrer
301-852-1167
rebecca.ferrer@nih.gov
PAR Basic Biobehavioral and Psychological Sciences
Notice of Additional Due Date and Additional "Areas of Focus Especially of Interest" of PAR-19-373 and PAR-19-384, "Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01)" NOT-OD-20-103 March 18, 2021

Rebecca Ferrer
301-852-1167
rebecca.ferrer@nih.gov

Notices - including Notices of Special Interest (NOSIs) Basic Biobehavioral and Psychological Sciences
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression Announcement Numbers PA-18-738 R01 Clinical Trial Optional May 08, 2021 Tram Lam
240-276-6967
lamt@mail.nih.gov
PA Epidemiology and Genomics Research
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression Announcement Numbers PA-18-739 R21 Clinical Trial Optional May 08, 2021 Tram Lam
240-276-6967
lamt@mail.nih.gov
PA Epidemiology and Genomics Research
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility PA-18-677 R01 Clinical Trial Not Allowed May 08, 2021 Tram Lam
240-276-6967
lamt@mail.nih.gov
PA Epidemiology and Genomics Research
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility PA-18-678 R21 Clinical Trial Not Allowed May 08, 2021 Tram Lam
240-276-6967
lamt@mail.nih.gov
PA Epidemiology and Genomics Research
Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer PA-18-492 R21 Clinical Trial Optional May 08, 2021 Gurvaneet Randhawa
240-276-6940
gurvaneet.randhawa@nih.gov
PA Healthcare Delivery Research, Cancer Survivorship, Implementation Science
Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer PA-18-493 R01 Clinical Trial Optional May 08, 2021 Gurvaneet Randhawa
240-276-6940
gurvaneet.randhawa@nih.gov
PA Healthcare Delivery Research, Cancer Survivorship, Implementation Science
Tobacco Regulatory Science RFA-OD-19-028 R01 Clinical Trial Optional February 14, 2021 Rachel Grana Mayne
240-276-5899
rachel.mayne@nih.gov
RFA Tobacco Control Research
Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the U.S.: The Role of Risk and Protective Factors PAR-19-018 R01 Clinical Trial Not Allowed March 05, 2021 Damali Martin
240-276-6746
martinda@mail.nih.gov
PAR Health Disparities, Epidemiology and Genomics Research
Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the U.S.: The Role of Risk and Protective Factors PAR-19-019 R21 Clinical Trial Not Allowed March 05, 2021 Damali Martin
240-276-6746
martinda@mail.nih.gov
PAR Health Disparities, Epidemiology and Genomics Research
Leveraging Health Information Technology (Health IT) to Address Minority Health and Health Disparities PAR-19-093 R01 Clinical Trial Optional March 05, 2021 April Oh
240-276-6709
april.oh@nih.gov
PAR Health Communication and Informatics Research, Implementation Science
Modular R01s in Cancer Control and Population Sciences PAR-18-869 R01 Clinical Trial Optional March 09, 2021 Scott Rogers
240-276-6932
rogerssc@mail.nih.gov
PAR Parent and Omnibus Funding Announcements, Epidemiology and Genomics Research, Implementation Science
Maximizing the Scientific Value of Existing Biospecimen Collections RFA-OD-19-021 R21 Clinical Trial Not Allowed March 09, 2021 Rachel Grana Mayne
240-276-5899
rachel.mayne@nih.gov
RFA Tobacco Control Research
Early-life Factors and Cancer Development Later in Life PA-18-532 R21 Clinical Trial Not Allowed January 08, 2021 Somdat Mahabir
240-276-6941
Mahabir@mail.nih.gov
PA Epidemiology and Genomics Research
Academic Research Enhancement Award PA-18-504 R15 January 08, 2021 Shobha Srinivasan
240-276-6938
sriniva2@mail.nih.gov
PA Health Disparities
Testing Interventions for Health-Enhancing Physical Activity PAR-18-324 R01 Clinical Trial Optional January 08, 2021 Frank Perna
240-276-6782
pernafm@mail.nih.gov
PAR Health Behaviors Research
Testing Interventions for Health-Enhancing Physical Activity PAR-18-307 R21, R33 Clinical Trial Optional January 08, 2021 Frank Perna
240-276-6782
pernafm@mail.nih.gov
PAR Health Behaviors Research
Notice of Special Interest (NOSI) Research to Advance the Understanding of Tobacco Product Pharmacokinetic Research NOT-OD-20-081 February 13, 2021 Rachel Grana Mayne
240-276-5899
rachel.mayne@nih.gov
Notices - including Notices of Special Interest (NOSIs) Tobacco Control Research
Research Answers to National Cancer Institute's (NCI) Provocative Questions RFA-CA-20-004 R01 Clinical Trial Optional November 18, 2020

Sean Hanlon
240-781-3310
sean.hanlon@nih.gov

RFA Cancer Survivorship, Epidemiology and Genomics Research, Health Behaviors Research, Healthcare Delivery Research, Health Disparities, Parent and Omnibus Funding Announcements
Cancer Prevention and Control Clinical Trials Grant Program PAR-21-035 R01 Clinical Trial Required January 08, 2024

Susan Czajkowski
240-276-5871
Susan.Czajkowski@nih.gov

PAR Implementation Science, Parent and Omnibus Funding Announcements
Academic Research Enhancement Award PA-18-343 R15 Clinical Trial Required January 08, 2021

April Oh
240-276-6709
april.oh@nih.gov

PA, Parent Announcements Parent and Omnibus Funding Announcements
NIH Research Project Grant PA-20-185 R01 Clinical Trial Not Allowed May 08, 2023

Research Program Contacts

PA, Parent Announcements Parent and Omnibus Funding Announcements
Assay Validation of High Quality Markers for Clinical Studies in Cancer PAR-18-317 UH2, UH3 Clinical Trial Not Allowed January 08, 2021

Mukesh Verma
240-276- 6889 vermam@mail.nih.gov

Rao Divi
240-276-6913
divir@mail.nih.gov

PAR Epidemiology and Genomics Research
Early-life Factors and Cancer Development Later in Life PA-18-531 R03 Clinical Trial Not Allowed January 08, 2021 Somdat Mahabir
240-276-6941
Mahabir@mail.nih.gov
PA Epidemiology and Genomics Research
Early-life Factors and Cancer Development Later in Life PA-18-529 R01 Clinical Trial Not Allowed January 08, 2021 Somdat Mahabir
240-276-6941
Mahabir@mail.nih.gov
PA Epidemiology and Genomics Research
Ethical, Legal, and Social Implications (ELSI) of Genomics Research Grant Program PAR-20-254 R01 July 23, 2023

Charlisse Caga-anan
240-276-6738
charlisse.caga-anan@nih.gov

PAR Epidemiology and Genomics Research
Ethical, Legal, and Social Implications (ELSI) of Genomics Research Grant Program PAR-20-255 R21 July 20, 2023

Charlisse Caga-anan
240-276-6738
charlisse.caga-anan@nih.gov

PAR Epidemiology and Genomics Research
Ethical, Legal, and Social Implications (ELSI) of Genomics Research Grant Program PAR-20-257 R03 July 20, 2023

Charlisse Caga-anan
240-276-6738
charlisse.caga-anan@nih.gov

PAR Epidemiology and Genomics Research
Research to Improve Native American Health (R21 Clinical Trials Optional) PAR-20-214 R21 September 08, 2023

Shobha Srinivasan
240-276-6938
sriniva2@mail.nih.gov

PAR Health Disparities
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes PAR-20-276 R01 September 08, 2022

Melissa Rotunno
240-276-7245
rotunnom@mail.nih.gov

PAR Epidemiology and Genomics Research
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes PAR-20-277 R21 September 08, 2022

Melissa Rotunno
240-276-7245
rotunnom@mail.nih.gov

PAR Epidemiology and Genomics Research
Intervention Research to Improve Native American Health PAR-20-238 R01 September 08, 2023

Shobha Srinivasan
240-276-6938
sriniva2@mail.nih.gov

PAR Health Disparities
Notice of Special Interest (NOSI): Smart and Connected Health (National Science Foundation - NIH Interagency Initiative) NOT-OD-13-041

April Oh
240-276-6709
april.oh@nih.gov

Notices - including Notices of Special Interest (NOSIs) Health Communication and Informatics Research

Go to the Archive of Funding Opportunities for information on recent funding announcements. Visit the Cancer Control Research section of this website for descriptive information on currently funded grants in this area.